Erik Ostrowski, SVP, CFO, CBO & Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 82,628 shares at $3.67 ($303K) on 2025-06-30, disclosed to the SEC on 2025-07-01.
Scheduled sale ($303k) by SVP, CFO, CBO & Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.67 | 41,314 | $152K | 50.0% |
| 2 | $3.67 | 41,314 | $152K | 50.0% |
| Total | $3.67 avg | 82,628 | $303K | 100% |
| Filing → |